Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Antibody-drug conjugates ace the tolerability test

Nature Biotechnology volume 26, pages 884–885 (2008)Cite this article

Near-uniform, low-level conjugation of cytotoxins to antitumor antibodies increases their tolerability without compromising efficacy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Schematic representation of site-specific conjugation of potent cytotoxic drugs (red stars) to a conventional IgG monoclonal antibody (mAb) or a THIOMAB—a mAb carrying the A114C mutation in the heavy chain.

References

  1. Carter, P.J. & Senter, P.D. Cancer J. 14, 154–169 (2008).

    Article  CAS  Google Scholar 

  2. Wu, A.M. & Senter, P.D. Nat. Biotechnol. 23, 1137–1146 (2005).

    Article  CAS  Google Scholar 

  3. Lambert, J.M. Curr. Opin. Pharmacol. 5, 543–549 (2005).

    Article  CAS  Google Scholar 

  4. Damle, N.K. Expert Opin. Biol. Ther. 4, 1445–1452 (2004).

    Article  CAS  Google Scholar 

  5. Junutula et al. Nat. Biotechnol. 26, 925–932 (2008).

    Article  CAS  Google Scholar 

  6. Sun, M.M. et al. Bioconjug. Chem. 16, 1282–1290 (2005).

    Article  CAS  Google Scholar 

  7. McDonagh, C.F. et al. Protein Eng. Des. Sel. 7, 299–307 (2006).

    Article  Google Scholar 

  8. Hamblett, K.J. et al. Clin. Cancer Res. 10, 7063–7070 (2004).

    Article  CAS  Google Scholar 

  9. Scott, A.M. et al. J. Clin. Oncol. 26, Abstract 3025, presented at the 44th annual ASCO meeting, Chicago, IL, May 30–June 3, 2008.

Download references

Author information

Authors and Affiliations

  1. Nitin K. Damle was in the Oncology Discovery Research Division of Wyeth Research, Pearl River, New York 10965, USA. ndamle56@gmail.com,

    Nitin K Damle

Authors
  1. Nitin K Damle
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Damle, N. Antibody-drug conjugates ace the tolerability test. Nat Biotechnol 26, 884–885 (2008). https://doi.org/10.1038/nbt0808-884

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0808-884

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing